These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29602751)

  • 1. Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial.
    Smit MR; Ochomo EO; Aljayyoussi G; Kwambai TK; Abong'o BO; Chen T; Bousema T; Slater HC; Waterhouse D; Bayoh NM; Gimnig JE; Samuels AM; Desai MR; Phillips-Howard PA; Kariuki SK; Wang D; Ward SA; Ter Kuile FO
    Lancet Infect Dis; 2018 Jun; 18(6):615-626. PubMed ID: 29602751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Direct Skin Feeding Versus Membrane Feeding to Assess the Mosquitocidal Efficacy of High-Dose Ivermectin (IVERMAL Trial).
    Smit MR; Ochomo EO; Aljayyoussi G; Kwambai TK; Abong'o BO; Bousema T; Waterhouse D; Bayoh NM; Gimnig JE; Samuels AM; Desai MR; Phillips-Howard PA; Kariuki SK; Wang D; Ward SA; Ter Kuile FO
    Clin Infect Dis; 2019 Sep; 69(7):1112-1119. PubMed ID: 30590537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya.
    Smit MR; Ochomo E; Aljayyoussi G; Kwambai T; Abong'o B; Bayoh N; Gimnig J; Samuels A; Desai M; Phillips-Howard PA; Kariuki S; Wang D; Ward S; Ter Kuile FO
    JMIR Res Protoc; 2016 Nov; 5(4):e213. PubMed ID: 27856406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-Prolongation (IVERMAL).
    Smit MR; Ochomo EO; Waterhouse D; Kwambai TK; Abong'o BO; Bousema T; Bayoh NM; Gimnig JE; Samuels AM; Desai MR; Phillips-Howard PA; Kariuki SK; Wang D; Ter Kuile FO; Ward SA; Aljayyoussi G
    Clin Pharmacol Ther; 2019 Feb; 105(2):388-401. PubMed ID: 30125353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia.
    Dabira ED; Soumare HM; Conteh B; Ceesay F; Ndiath MO; Bradley J; Mohammed N; Kandeh B; Smit MR; Slater H; Peeters Grietens K; Broekhuizen H; Bousema T; Drakeley C; Lindsay SW; Achan J; D'Alessandro U
    Lancet Infect Dis; 2022 Apr; 22(4):519-528. PubMed ID: 34919831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial.
    Dicko A; Brown JM; Diawara H; Baber I; Mahamar A; Soumare HM; Sanogo K; Koita F; Keita S; Traore SF; Chen I; Poirot E; Hwang J; McCulloch C; Lanke K; Pett H; Niemi M; Nosten F; Bousema T; Gosling R
    Lancet Infect Dis; 2016 Jun; 16(6):674-684. PubMed ID: 26906747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.
    Muhindo MK; Jagannathan P; Kakuru A; Opira B; Olwoch P; Okiring J; Nalugo N; Clark TD; Ruel T; Charlebois E; Feeney ME; Havlir DV; Dorsey G; Kamya MR
    Lancet Infect Dis; 2019 Sep; 19(9):962-972. PubMed ID: 31307883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial.
    Stone W; Mahamar A; Smit MJ; Sanogo K; Sinaba Y; Niambele SM; Sacko A; Keita S; Dicko OM; Diallo M; Maguiraga SO; Samake S; Attaher O; Lanke K; Ter Heine R; Bradley J; McCall MBB; Issiaka D; Traore SF; Bousema T; Drakeley C; Dicko A
    Lancet Microbe; 2022 May; 3(5):e336-e347. PubMed ID: 35544095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.
    Ouédraogo AL; Bastiaens GJ; Tiono AB; Guelbéogo WM; Kobylinski KC; Ouédraogo A; Barry A; Bougouma EC; Nebie I; Ouattara MS; Lanke KH; Fleckenstein L; Sauerwein RW; Slater HC; Churcher TS; Sirima SB; Drakeley C; Bousema T
    Clin Infect Dis; 2015 Feb; 60(3):357-65. PubMed ID: 25414262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study.
    Slater HC; Foy BD; Kobylinski K; Chaccour C; Watson OJ; Hellewell J; Aljayyoussi G; Bousema T; Burrows J; D'Alessandro U; Alout H; Ter Kuile FO; Walker PGT; Ghani AC; Smit MR
    Lancet Infect Dis; 2020 Apr; 20(4):498-508. PubMed ID: 31948767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
    Desai M; Gutman J; L'lanziva A; Otieno K; Juma E; Kariuki S; Ouma P; Were V; Laserson K; Katana A; Williamson J; ter Kuile FO
    Lancet; 2015 Dec; 386(10012):2507-19. PubMed ID: 26429700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent
    Stone W; Mahamar A; Sanogo K; Sinaba Y; Niambele SM; Sacko A; Keita S; Youssouf A; Diallo M; Soumare HM; Kaur H; Lanke K; Ter Heine R; Bradley J; Issiaka D; Diawara H; Traore SF; Bousema T; Drakeley C; Dicko A
    Lancet Microbe; 2022 Jan; 3(1):e41-e51. PubMed ID: 35028628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.
    Sissoko MS; Healy SA; Katile A; Omaswa F; Zaidi I; Gabriel EE; Kamate B; Samake Y; Guindo MA; Dolo A; Niangaly A; Niaré K; Zeguime A; Sissoko K; Diallo H; Thera I; Ding K; Fay MP; O'Connell EM; Nutman TB; Wong-Madden S; Murshedkar T; Ruben AJ; Li M; Abebe Y; Manoj A; Gunasekera A; Chakravarty S; Sim BKL; Billingsley PF; James ER; Walther M; Richie TL; Hoffman SL; Doumbo O; Duffy PE
    Lancet Infect Dis; 2017 May; 17(5):498-509. PubMed ID: 28216244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entomological impact of mass administration of ivermectin and dihydroartemisinin-piperaquine in The Gambia: a cluster-randomized controlled trial.
    Soumare HM; Dabira ED; Camara MM; Jadama L; Gaye PM; Kanteh S; Jawara EA; Njie AK; Sanneh F; Ndiath MO; Lindsay SW; Conteh B; Ceesay S; Mohammed N; Ooko M; Bradley J; Drakeley C; Erhart A; Bousema T; D'Alessandro U
    Parasit Vectors; 2022 Nov; 15(1):435. PubMed ID: 36397132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects.
    Kobylinski KC; Jittamala P; Hanboonkunupakarn B; Pukrittayakamee S; Pantuwatana K; Phasomkusolsil S; Davidson SA; Winterberg M; Hoglund RM; Mukaka M; van der Pluijm RW; Dondorp A; Day NPJ; White NJ; Tarning J
    Clin Pharmacol Ther; 2020 May; 107(5):1221-1230. PubMed ID: 31697848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.
    Manning J; Vanachayangkul P; Lon C; Spring M; So M; Sea D; Se Y; Somethy S; Phann ST; Chann S; Sriwichai S; Buathong N; Kuntawunginn W; Mitprasat M; Siripokasupkul R; Teja-Isavadharm P; Soh E; Timmermans A; Lanteri C; Kaewkungwal J; Auayporn M; Tang D; Chour CM; Prom S; Haigney M; Cantilena L; Saunders D
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6056-67. PubMed ID: 25092702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.
    Held J; Supan C; Salazar CL; Tinto H; Bonkian LN; Nahum A; Moulero B; Sié A; Coulibaly B; Sirima SB; Siribie M; Otsyula N; Otieno L; Abdallah AM; Kimutai R; Bouyou-Akotet M; Kombila M; Koiwai K; Cantalloube C; Din-Bell C; Djeriou E; Waitumbi J; Mordmüller B; Ter-Minassian D; Lell B; Kremsner PG
    Lancet Infect Dis; 2015 Dec; 15(12):1409-19. PubMed ID: 26342427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.